Odyssean »

Adma Biologics shares owned by Odyssean

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 125k 8.37

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Capital Research Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
First Trust Advisors
Nuveen
Geode Capital Management
D. E. Shaw & Co
Caligan Partners
Bank of America Corporation
Dimensional Fund Advisors
Goldman Sachs Group
Millennium Management
Caption Management

View all funds holding Adma Biologics